BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32384903)

  • 1. Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products.
    Lu A; Liu H; Shi R; Cai Y; Ma J; Shao L; Rong V; Gkitsas N; Lei H; Highfill SL; Panch S; Stroncek DF; Jin P
    J Transl Med; 2020 May; 18(1):191. PubMed ID: 32384903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays.
    Ma J; Shao L; Fuksenko T; Liu H; Shi R; Dinh A; Highfill SL; Zhang N; Panch SR; Somerville RP; Stroncek DF; Jin P
    Cytotherapy; 2023 Jun; 25(6):598-604. PubMed ID: 36935289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
    Haderbache R; Warda W; Hervouet E; da Rocha MN; Trad R; Allain V; Nicod C; Thieblemeont C; Boissel N; Varlet P; Agha IY; Bouquet L; Guiot M; Venet F; Sujobert P; Roussel X; Rouzaire PO; Caillot D; Casasnovas O; Bories JC; Bachy E; Caillat-Zucman S; Deschamps M; Ferrand C
    J Transl Med; 2021 Jun; 19(1):265. PubMed ID: 34154602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products.
    Murphy LA; Marians RC; Miller K; Brenton MD; Mallo RLV; Kohler ME; Fry TJ; Winters AC
    Cytotherapy; 2023 Jan; 25(1):94-102. PubMed ID: 36253252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control.
    Cai Y; Prochazkova M; Jiang C; Song HW; Jin J; Moses L; Gkitsas N; Somerville RP; Highfill SL; Panch S; Stroncek DF; Jin P
    J Transl Med; 2021 Dec; 19(1):523. PubMed ID: 34952597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR.
    Lou Y; Chen C; Long X; Gu J; Xiao M; Wang D; Zhou X; Li T; Hong Z; Li C; Zhou J; Chen L
    J Mol Diagn; 2020 May; 22(5):699-707. PubMed ID: 32409121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of integrated vector copy number by multiplex droplet digital PCR in dual-transduced CAR T cells.
    Wang W; Al-Hajj M; Alavi AS
    Mol Ther Methods Clin Dev; 2023 Sep; 30():403-410. PubMed ID: 37622159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Applicable Assessment of Tisagenlecleucel CAR T Cell Treatment by Digital Droplet PCR for Copy Number Variant Assessment.
    Gkazi SA; Gravett E; Bautista C; Bartram J; Ghorashian S; Adams SP
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of integrated and free transcripts in chimeric antigen receptor T-cell manufactured cell products using droplet digital polymerase chain reaction.
    Wiltshire TD; Milosevic D; Jacob EK; Grebe SK; Dietz AB
    Cytotherapy; 2021 May; 23(5):452-458. PubMed ID: 33715950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on Droplet Digital PCR-Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Cell Therapy.
    Sugimoto H; Chen S; Minembe JP; Chouitar J; He X; Wang H; Fang X; Qian MG
    AAPS J; 2021 Mar; 23(2):36. PubMed ID: 33655393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices.
    Masilamani M; Jawa V; Dai Y; Das R; Park A; Lamba M; Wu F; Zheng X; Lu E; Gleason C; Mack T; Mora J; Surapaneni S
    Clin Pharmacol Ther; 2023 Sep; 114(3):664-672. PubMed ID: 37422675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients.
    Schubert ML; Berger C; Kunz A; Schmitt A; Badbaran A; Neuber B; Zeschke S; Wang L; Riecken K; Hückelhoven-Krauss A; Müller I; Müller-Tidow C; Dreger P; Kröger N; Ayuk FA; Schmitt M; Fehse B
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35294040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring anti-CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction.
    Cheng J; Mao X; Chen C; Long X; Chen L; Zhou J; Zhu L
    Cytometry A; 2023 Jan; 103(1):16-26. PubMed ID: 35875964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR).
    Galli E; Viscovo M; Fosso F; Pansini I; Di Cesare G; Iacovelli C; Maiolo E; Sorà F; Hohaus S; Sica S; Bellesi S; Chiusolo P
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue.
    Pullarkat S; Black G; Bleakley M; Buenrostro D; Chapuis AG; Hirayama AV; Jaeger-Ruckstuhl CA; Kimble EL; Lee BM; Maloney DG; Radich J; Seaton BW; Specht JM; Turtle CJ; Woolston DW; Wright JH; Yeung CCS
    PLoS One; 2024; 19(6):e0303057. PubMed ID: 38843256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy.
    Kao RL; Truscott LC; Chiou TT; Tsai W; Wu AM; De Oliveira SN
    Hum Gene Ther; 2019 Apr; 30(4):413-428. PubMed ID: 30860401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
    Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
    J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered T Cell Therapy for Cancer in the Clinic.
    Zhao L; Cao YJ
    Front Immunol; 2019; 10():2250. PubMed ID: 31681259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TCR-based Chimeric Antigen Receptor.
    Walseng E; Köksal H; Sektioglu IM; Fåne A; Skorstad G; Kvalheim G; Gaudernack G; Inderberg EM; Wälchli S
    Sci Rep; 2017 Sep; 7(1):10713. PubMed ID: 28878363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
    Wang L; Gong W; Wang S; Neuber B; Sellner L; Schubert ML; Hückelhoven-Krauss A; Kunz A; Gern U; Michels B; Hinkelbein M; Mechler S; Richter P; Müller-Tidow C; Schmitt M; Schmitt A
    Cytotherapy; 2019 May; 21(5):566-578. PubMed ID: 30910382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.